CSL Limited
Corporate / Biotech
Australia
CSL Limited has 1 documented commitment as of 2026. Typical fund size 150-400M. Most active in Europe.
Distinct funds backed1
Typical fund size150-400M
LPs seen in the same funds3
Sectors backedTherapeutic biotech
Active on record2026
Documented commitments1
HeadquartersMelbourne, Australia
Geographic focusGlobal · Europe
Most recent fund backedKurma Partners Biofund IV
Mandate
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.